Loading...
Loading...
Application UK00801482018 · Registered
| Application Number | UK00801482018 |
| Status | Registered |
| Owner | Inreda Diabetic B.V. |
| Filed | 2019-05-31 |
| Registered | 2020-01-14 |
| Renewal Due | 2029-05-31 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. INREDA is currently a registered UK trademark, with renewal due on 2029-05-31. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical and hormonal agents and preparations for the treatment of diabetes.
Apparatus and instruments for controlling, regulating and monitoring artificial organs; apparatus and instruments for regulating blood sugar levels, both internal and external; artificial organs and implants, including artificial pancreas.
Wholesale and retail services relating to medical devices and instruments for the control, regulation and monitoring of artificial organs, artificial organs and implants and related pharmaceutical preparations.
Design and development of medical devices and instruments (for and on behalf of third parties).
'INREDA' is a registered trademark on the UK IPO register, owned by Inreda Diabetic B.V.. The application (UK00801482018) was filed on 31 May 2019 and registered on 14 January 2020. The registration is set to expire on 31 May 2029.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus); Class 35 (advertising, business management & retail services); Class 42 (scientific, IT & design services).
The trademark is represented by Arnold & Siedsma.
UK trademark UK00801482018 for the mark 'INREDA' in Class 5, 10, 35, 42 is recorded on the UK IPO register as owned by Inreda Diabetic B.V.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00801482018 for the mark 'INREDA' as registered.
UK trademark UK00801482018 for the mark 'INREDA' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus); Class 35 (advertising, business management & retail services); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceutical and hormonal agents and preparations for the treatment of diabetes. | Class 10: Apparatus and instruments for controlling, regulating and monitoring artificial organs; apparatus and instruments for regulating blood sugar levels, both internal and external; artificial organs and implants, incl…
UK trademark UK00801482018 for the mark 'INREDA' was filed at the UK IPO on 31 May 2019 and registered on 14 January 2020.
UK trademark UK00801482018 for the mark 'INREDA' is currently recorded as valid until 31 May 2029, at which point it will need to be renewed with the UK IPO to remain in force.
Arnold & Siedsma is listed as the attorney / representative of record for UK trademark UK00801482018 for the mark 'INREDA' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.